2595 — GenFleet Therapeutics (Shanghai) Balance Sheet
0.000.00%
Last trade - 00:00- HK$9.57bn
- HK$9.27bn
- CNY104.70m
Annual balance sheet for GenFleet Therapeutics (Shanghai), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 332 | 395 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 82.4 | 135 |
| Total Inventory | ||
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 451 | 568 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 44 | 27.7 |
| Net Intangible Assets | ||
| Long Term Investments | ||
| Other Long Term Assets | ||
| Total Assets | 536 | 607 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 1,832 | 2,493 |
| Capital Lease Obligations | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 1,853 | 2,563 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Other Equity | ||
| Total Equity | -1,317 | -1,956 |
| Total Liabilities & Shareholders' Equity | 536 | 607 |
| Total Common Shares Outstanding |